本頁面由Tiger Trade Technology Pte. Ltd.提供服務

福泰製藥

548.05
+7.791.44%
盤後548.050.00000.00%19:52 EDT
成交量:107.50萬
成交額:5.90億
市值:1,390.51億
市盈率:31.90
高:555.32
開:545.10
低:540.70
收:540.26
52周最高:555.32
52周最低:374.17
股本:2.54億
流通股本:2.54億
量比:0.86
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):17.18
每股收益(LYR):15.32
淨資產收益率:23.54%
總資產收益率:11.93%
市淨率:6.87
市盈率(LYR):35.77

資料載入中...

2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/07

重要事件披露

Form 8-K - Current report
2026/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments